Temozolomide News and Research

RSS
KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

Giving chemotherapy in the morning can extend survival of glioblastoma patients

Giving chemotherapy in the morning can extend survival of glioblastoma patients

Study: Reduced activity of specific enzyme leads to much higher cancer rates

Study: Reduced activity of specific enzyme leads to much higher cancer rates

Three projects from University of Colorado Cancer Center receive grants for brain tumor research

Three projects from University of Colorado Cancer Center receive grants for brain tumor research

New glioma-targeted nano-therapeutic offers a potential treatment for glioblastomas

New glioma-targeted nano-therapeutic offers a potential treatment for glioblastomas

Mice study suggests novel approach to treat a type of common glioma

Mice study suggests novel approach to treat a type of common glioma

Scientists avert drug resistance in subtype of brain tumors

Scientists avert drug resistance in subtype of brain tumors

Researchers analyze outcomes in patients with primary central nervous system lymphoma

Researchers analyze outcomes in patients with primary central nervous system lymphoma

Preliminary analysis of photon therapy treatment group 1 shows no significant differences between arms

Preliminary analysis of photon therapy treatment group 1 shows no significant differences between arms

FDA grants rare disease designations to investigational brain tumor drug

FDA grants rare disease designations to investigational brain tumor drug

Researchers develop novel approach for utilizing 4D-printing of arrays to accelerate drug testing

Researchers develop novel approach for utilizing 4D-printing of arrays to accelerate drug testing

CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

UVA scientists identify oncogene responsible for deadliest brain tumor

UVA scientists identify oncogene responsible for deadliest brain tumor

Researchers uncover a potentially promising strategy to target brain tumors

Researchers uncover a potentially promising strategy to target brain tumors

Antimalarial drug shows promise as potential therapy for aggressive brain cancer

Antimalarial drug shows promise as potential therapy for aggressive brain cancer

Combination therapy boosts the immune system's appetite for cancer

Combination therapy boosts the immune system's appetite for cancer

Removing 'non-contrast enhancing tumor' may boost survival of glioblastoma patients

Removing 'non-contrast enhancing tumor' may boost survival of glioblastoma patients

Expanded Medication Assistance Program increases access to vital cancer therapies

Expanded Medication Assistance Program increases access to vital cancer therapies

Improved microfluidic brain chip can assess the effectiveness of cancer drugs in record time

Improved microfluidic brain chip can assess the effectiveness of cancer drugs in record time

Researchers identify new mechanism associated with p53 mutation

Researchers identify new mechanism associated with p53 mutation